Hypothyroidism (HoT) treatment involves lifelong thyroxine replacement therapy and regular monitoring. The objective of this study was to assess the impact of clinical pharmacist (CP) intervention in managing drug-related problems (DRPs) on outcomes among hypothyroid patients receiving levothyroxine (LT4) therapy.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Acceptance rate of suggested intervention (number)
Timeframe: From the date of randomization until there are 18 patient participants in each group. Average 6 months.
Serum Thyroid Stimulating Hormone Levels
Timeframe: From the date of randomization until there are 18 patient participants in each group. Average 6 months.
Having serum T4 Levels within the normal range
Timeframe: From the date of randomization until there are 18 patient participants in each group. Average 6 months.
Change in medication adherence rate for patients with thyroid disorders
Timeframe: From the date of randomization until there are 18 patient participants in each group. Average 6 months.